TandemAI Closes $22M Series A Extension Round to Accelerate AI-Driven Drug Discovery
NEW YORK & BOSTON–(BUSINESS WIRE)–TandemAI announced it has secured a $22 million Series A extension to further develop its drug discovery platform, which combines advanced AI, physics-based computational methods, and wet lab capabilities. The round…